CLINICAL TRIALS
Active clinical trials and verified researcher listings for Kidney / Renal Cell Carcinoma, simplified into plain English.
ABOUT KIDNEY / RENAL CELL CARCINOMA
In humans, the kidneys are two reddish-brown bean-shaped blood-filtering organs that are a multilobar, multipapillary form of mammalian kidneys, usually without signs of external lobulation. They are located on the left and right in the retroperitoneal space, and in adult humans are about 12 centimetres in length. They receive blood from the paired renal arteries; blood exits into the paired renal veins. Each kidney is attached to a ureter, a tube that carries excreted urine to the bladder.
Source: Wikipedia. For educational use only — not medical advice.
ACTIVELY RECRUITING TRIALS
COMMON QUESTIONS
Are there clinical trials currently recruiting for Kidney / Renal Cell Carcinoma?
Yes. This page displays actively recruiting Kidney / Renal Cell Carcinoma clinical trials sourced in real time from ClinicalTrials.gov. Use the filters to narrow by phase, status, and location.
How do I join a clinical trial for Kidney / Renal Cell Carcinoma?
Browse the trials listed above, review the eligibility criteria for each study, and submit a contact request directly to the research team. You can also speak to your physician about a referral.
Are Kidney / Renal Cell Carcinoma clinical trials free to participate in?
Most clinical trials cover the cost of the investigational treatment and all study-related visits. Some studies also offer compensation for time and travel. Always confirm costs and insurance coverage with the trial coordinator before enrolling.
What eligibility requirements apply to Kidney / Renal Cell Carcinoma trials?
Requirements vary by study. Common criteria include a confirmed Kidney / Renal Cell Carcinoma diagnosis, age range, prior treatments, and general health status. Each trial listing shows its specific inclusion and exclusion criteria.
What phases of Kidney / Renal Cell Carcinoma trials are available?
Kidney / Renal Cell Carcinoma trials span Phase I (safety testing), Phase II (effectiveness), Phase III (comparison to standard care), and Phase IV (post-approval monitoring). Phase II and III trials are most commonly open to new participants.